| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.79M | 78.18M | 49.13M | 68.03M | 56.05M | 31.42M |
| Gross Profit | 39.53M | 39.41M | 30.00M | 27.90M | 30.59M | 8.40M |
| EBITDA | 7.00M | 12.03M | -16.42M | -4.46M | 6.41M | -52.21M |
| Net Income | -1.19M | 3.60M | -21.41M | -9.73M | 2.21M | -62.82M |
Balance Sheet | ||||||
| Total Assets | 61.95M | 72.52M | 64.38M | 88.08M | 104.64M | 75.45M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 13.94M | 5.17M | 7.15M | 13.06M | 16.85M |
| Total Debt | 7.20M | 462.00K | 7.16M | 6.21M | 749.00K | 11.99M |
| Total Liabilities | 24.78M | 34.72M | 32.23M | 49.01M | 63.69M | 59.56M |
| Stockholders Equity | 38.03M | 38.75M | 33.27M | 40.34M | 42.25M | 17.24M |
Cash Flow | ||||||
| Free Cash Flow | -3.12M | 16.24M | -11.66M | -10.24M | 4.24M | -22.62M |
| Operating Cash Flow | -2.11M | 17.41M | -10.59M | -8.97M | 4.88M | -20.01M |
| Investing Cash Flow | -672.00K | -635.00K | -531.00K | -1.27M | -12.30M | -1.71M |
| Financing Cash Flow | 2.71M | -8.00M | 9.14M | 4.33M | 2.64M | 24.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
52 Neutral | $91.15M | -18.04 | -5.63% | ― | 12.98% | 27.93% | |
46 Neutral | $39.26M | ― | -3.49% | ― | 77.29% | 97.98% | |
46 Neutral | $28.28M | -0.39 | ― | ― | 88.72% | -85.54% | |
44 Neutral | $44.57M | -1.80 | ― | ― | 7.11% | 69.85% | |
43 Neutral | $46.87M | -1.71 | ― | ― | -32.17% | -135.06% | |
41 Neutral | $13.98M | -0.67 | -35.18% | ― | -14.24% | -104.12% |
On November 20, 2025, Cineverse Corp. amended its 2017 Equity Incentive Plan to increase the number of shares authorized for issuance from 2,504,913 to 3,504,913. During its Annual Meeting of Stockholders on the same day, all management nominees were elected to the Board of Directors, and several proposals were voted on, including the approval of executive compensation and the ratification of EisnerAmper LLP as independent auditors for the fiscal year ending March 31, 2026. The company also decided to include an annual advisory stockholder vote on executive compensation until at least 2031.
The most recent analyst rating on (CNVS) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Cineverse stock, see the CNVS Stock Forecast page.